Deltex Medical Group plc reported revenue results for the year ended December 31, 2015. For the year, the company reported sales broadly similar to the previous year at £6.4 million compared to £6.5 million in 2014, strong growth in US and other export markets offset by 21% fall in UK probe revenues and £0.3 million fall in UK monitor revenues due to continuing NHS funding issues. US probe revenues increased by 31% to £1.3 million, 23% increase on constant currency basis.

US growth driven by addition of 11 new Platform Accounts taking year end total to 17; and Total monitor revenues down £0.5 million of which UK £0.3 million with NHS Supply Chain order in 2014 not repeated.